http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M#head http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M#assertion http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M#provenance http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M#publicationInfo http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M#assertion http://bio2rdf.org/drugbank:DB01124 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB01124_DB01138 http://bio2rdf.org/drugbank:DB01138 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB01124_DB01138 http://bio2rdf.org/drugbank_resource:DB01124_DB01138 http://purl.org/dc/terms/identifier drugbank_resource:DB01124_DB01138 http://bio2rdf.org/drugbank_resource:DB01124_DB01138 http://purl.org/dc/terms/title DDI between Tolbutamide and Sulfinpyrazone - Tolbutamide, a strong CYP2C9 inhibitor, may decrease the metabolism and clearance of Sulfinpyrazone. Consider alternate therapy or monitor for changes in Sulfinpyrazone therapeutic and adverse effects if Tolbutamide is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB01124_DB01138 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB01124_DB01138 http://www.w3.org/2000/01/rdf-schema#label DDI between Tolbutamide and Sulfinpyrazone - Tolbutamide, a strong CYP2C9 inhibitor, may decrease the metabolism and clearance of Sulfinpyrazone. Consider alternate therapy or monitor for changes in Sulfinpyrazone therapeutic and adverse effects if Tolbutamide is initiated, discontinued or dose changed. [drugbank_resource:DB01124_DB01138] http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M#provenance http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M#publicationInfo http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M#signature.MCwCFC7oG0Tpcw6F http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M#signature.MCwCFC7oG0Tpcw6F http://purl.org/nanopub/x/hasSignature MCwCFC7oG0Tpcw6FiVBm5ZVETT+jnTskAhR7Kde7FPVpsYFwFAZBElwJtIIK2A== http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M#signature.MCwCFC7oG0Tpcw6F http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M http://purl.org/dc/terms/created 2018-03-30T11:13:15.345+02:00 http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M#signature.MCwCFC7oG0Tpcw6F http://bio2rdf.org/drugbank_resource:DB01124_DB01138_nanopub.RALXUia2pGiQGg4dTVQ8YpC6K408V6eJAUBn5cfzfjV6M http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234